Vaxcyte Ownership | Who Owns Vaxcyte?


OverviewForecastFinancialsChartTranscripts

Vaxcyte Ownership Summary


Vaxcyte is owned by 120.69% institutional investors, 0.49% insiders. Fmr is the largest institutional shareholder, holding 14.95% of PCVX shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 3.18% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVaxcyte120.69%0.49%-21.17%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr20.85M14.95%$1.21B
Janus henderson group16.58M12.18%$960.23M
Vanguard group12.19M8.95%$562.63M
T. rowe price investment management12.21M8.75%$709.62M
Blackrock funding, inc. /de12.07M8.65%$701.52M
Blackrock9.94M8.48%$750.56M
Ra capital management11.47M8.23%$667.02M
Wellington management group llp7.00M5.02%$407.00M
Vanguard capital management6.35M4.55%$369.05M
State street5.35M3.84%$311.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor1.43M26.92%$82.86M
University of wisconsin foundation239.75K11.03%$13.94M
Kynam capital management, lp2.92M9.39%$169.88M
Saturn v capital management852.91K7.11%$49.58M
Caligan partners lp2.19M5.99%$127.23M
Ra capital management11.47M5.80%$667.02M
Rosalind advisors200.00K4.32%$11.63M
Deep track capital, lp4.30M3.64%$249.96M
Ghost tree capital150.00K3.55%$11.33M
First turn management443.84K2.76%$25.80M

Top Buyers

HolderShares% AssetsChange
Fmr20.85M0.05%4.36M
Janus henderson group16.58M0.48%3.19M
Price t rowe associates inc /md/2.99M0.02%2.01M
Sixth street partners management company1.46M0.01%1.46M
Wellington management group llp7.00M0.07%1.39M

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp2.13M2.32%-2.67M
Darwin global management---2.20M
Commodore capital lp---1.65M
Farallon capital management---1.26M
Jennison associates476.22K0.02%-1.22M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.46M0.01%1.46M$85.15M
Norges bank1.25M0.01%1.25M$72.42M
First turn management443.84K2.76%443.84K$25.80M
Nicholas investment partners, lp131.13K0.43%131.13K$7.62M
Edgestream partners131.12K0.23%131.12K$7.62M

Sold Out

HolderChange
Global financial private client-1.00
Private wealth asset management-2.00
Tradewinds capital management-2.00
Capital performance advisors llp-3.00
Td private client wealth-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026348-0.85%168,369,7063.60%1200.89%185-7.50%9819.51%
Mar 31, 202634313.58%160,906,6599.04%1181.01%19423.57%80-23.81%
Dec 31, 2025136-53.58%40,972,706-71.00%300.28%69-52.08%44-55.56%
Sep 30, 2025123-58.16%39,571,115-72.00%290.27%52-71.58%52-29.73%
Jun 30, 2025302-7.93%147,482,0231.73%1080.95%183-2.66%77-20.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest4.61M3.18%16.41K
Vanguard Total Stock Mkt Idx Inv4.59M3.18%-2.14K
Vanguard Morn Total Stk Mkt Idx Investor4.59M3.18%-2.14K
Vanguard US Total Market Shares ETF3.67M2.85%587.74K
iShares Russell 2000 ETF3.35M2.32%-59.52K
Vanguard Small Cap Index3.32M2.29%8.14K
Strategic Advisers Fidelity US TtlStk3.13M2.17%95.50K
Janus Concentrated Growth CF2.68M1.85%435.65K
Janus Henderson Forty S2.68M1.85%-
Vanguard Health Care Inv2.67M1.85%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 09, 2026Wassil Jim EVP, Chief Scientific Ofc, COOSell$79.40K
Sep 04, 2026Wassil Jim EVP, Chief Scientific Ofc, COOSell$84.46K
Sep 01, 2026Wassil Jim CHIEF OPERATING OFFICERSell$93.58K
Sep 01, 2026Wassil Jim CHIEF OPERATING OFFICERSell$43.84K
Sep 01, 2026Wassil Jim CHIEF OPERATING OFFICERSell$56.32K

Insider Transactions Trends


DateBuySell
2026 Q3-22
2026 Q2-17
2026 Q1-5
2025 Q4-3
2025 Q3--

PCVX Ownership FAQ


Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 120.69%, followed by 0.49% insiders and -21.18% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 380.48%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (20.85M shares, 14.95%), Janus henderson group (16.58M shares, 12.18%), and Vanguard group (12.19M shares, 8.95%). Together, they hold 36.08% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 26.92% of its assets in 1.43M Vaxcyte shares, valued at 82.86M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Vaxcyte shares, with 3.18% of its total shares outstanding invested in 4.61M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools